Skip to main content

Medications for Colorectal Cancer

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Alymsys Rate Add review
Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Avastin 5.5 3 reviews for Avastin to treat Colorectal Cancer
Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Avzivi Rate Add review
Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
Betaseron Rate Add review
Rx C N X
Generic name:
interferon beta-1b systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
bevacizumab 5.5 3 reviews for bevacizumab to treat Colorectal Cancer
Rx C N
Generic name:
bevacizumab systemic
Brand names:
Avastin, Mvasi, Zirabev, Alymsys, Avzivi, Vegzelma
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Braftovi 1.0 1 review for Braftovi to treat Colorectal Cancer
Rx N
Generic name:
encorafenib systemic
Drug class:
multikinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Camptosar 5.0 1 review for Camptosar to treat Colorectal Cancer
Rx D N
Generic name:
irinotecan systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
capecitabine 8.5 18 reviews for capecitabine to treat Colorectal Cancer
Rx D N
Generic name:
capecitabine systemic
Brand name:
Xeloda
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cetuximab 7.8 4 reviews for cetuximab to treat Colorectal Cancer
Rx C N
Generic name:
cetuximab systemic
Brand name:
Erbitux
Drug class:
EGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Cyramza Rate Add review
Rx C N
Generic name:
ramucirumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Eloxatin Rate Add review
Rx D N
Generic name:
oxaliplatin systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
encorafenib 1.0 1 review for encorafenib to treat Colorectal Cancer
Rx N
Generic name:
encorafenib systemic
Brand name:
Braftovi
Drug class:
multikinase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Erbitux 7.8 4 reviews for Erbitux to treat Colorectal Cancer
Rx C N
Generic name:
cetuximab systemic
Drug class:
EGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
fluorouracil 1.0 2 reviews for fluorouracil to treat Colorectal Cancer
Rx D N
Generic name:
fluorouracil systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
fruquintinib Rate Add review
Rx N
Generic name:
fruquintinib systemic
Brand name:
Fruzaqla
Drug class:
multikinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Fruzaqla Rate Add review
Rx N
Generic name:
fruquintinib systemic
Drug class:
multikinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Fusilev Rate Add review
Rx C N
Generic name:
levoleucovorin systemic
Drug class:
antidotes
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
interferon beta-1b Rate Add review
Rx C N X
Generic name:
interferon beta-1b systemic
Brand name:
Betaseron
Drug class:
interferons
For consumers:
dosage, interactions, side effects
ipilimumab Rate Add review
Rx C N
Generic name:
ipilimumab systemic
Brand name:
Yervoy
Drug class:
anti-CTLA-4 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
irinotecan 3.0 3 reviews for irinotecan to treat Colorectal Cancer
Rx D N
Generic name:
irinotecan systemic
Brand name:
Camptosar
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Keytruda 4.5 2 reviews for Keytruda to treat Colorectal Cancer
Rx D N
Generic name:
pembrolizumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Khapzory Rate Add review
Rx C N
Generic name:
levoleucovorin systemic
Drug class:
antidotes
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
leucovorin Rate Add review
Rx C N
Generic name:
leucovorin systemic
Drug class:
antidotes
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
levoleucovorin Rate Add review
Rx C N
Generic name:
levoleucovorin systemic
Brand names:
Fusilev, Khapzory
Drug class:
antidotes
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Lonsurf Rate Add review
Rx N
Generic name:
tipiracil / trifluridine systemic
Drug class:
antineoplastic combinations
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Topics under Colorectal Cancer

Learn more about Colorectal Cancer

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.